Robin F. Marchant
Robin Marchant has acted for private and public corporations, private equity funds and investment banks based in the U.K., the U.S., Europe and Russia on a broad range of corporate and commercial work.

Bio

Mr. Marchant's practice has included private and public M&A, private equity transactions, equity and debt security issues, share capital restructurings and buy-backs, project finance, and general corporate matters. He is recognized in the Russia Corporate/M&A: High-End Capability section of Chambers Europe.

Mr. Marchant’s experience has included advising:

  • Fresenius Kabi AG in its proposed joint venture with Sistema to combine their respective pharmaceutical businesses;
  • Revlon in its acquisition by way of auction of The Colomer Group from CVC Capital Partners’ funds for US$665 million;
  • Daimler AG in relation to its acquisition of stakes in Kamaz, Russia’s leading trucks manufacturer, and the creation of a joint venture with Rostec;
  • Megapolis, Russia’s leading tobacco distributor, in relation to the creation of a US$2 billion joint venture with Philip Morris and Japan Tobacco, each acquiring a 20 percent stake in Megapolis Distribution BV;
  • Renault and Nissan in relation to acquisitions by Renault of stakes in Avtovaz, Russia’s leading car manufacturer, and the creation of a US$3 billion joint venture between the Renault-Nissan alliance and Rostec, giving the Renault-Nissan alliance control;
  • Wm. Wrigley. Jr. Company in its acquisition of premium Russian chocolatier A. Korkunov, and in the establishment of a joint venture with Mr. Korkunov; as well as in its later merger with Mars, Incorporated;
  • Svoboda Corporation in various acquisitions, joint venture creations and corporate reorganizations in relation to various retail businesses, including Ulmart and Rive Gauche;
  • CME Group, the world’s leading derivatives marketplace, in relation to its acquisition of Elysian Systems Ltd., an independent provider of electronic trading and market technology;
  • Renaissance Partners in relation to the creation of a joint venture for the establishment of a soya protein processing plant in Finland;
  • Simon Glick Investments in relation to the restructuring and refinancing of Songbird Estates (a majority shareholder of Canary Wharf Group plc) and the creation of a warrant funding instrument;
  • TPG Capital in relation to Vita Group’s restructuring by means of a creditors’ and members’ scheme of arrangement;
  • the management of Vita Group in relation to the creation of its equity incentive scheme;
  • Berkeley Group Holdings in its return of £13 per share to shareholders and creation of long-term incentive plan for management;
  • Imerys SA in its US$652.8 million acquisition of S&B Industrial Minerals GmbH, both companies being producers of industrial minerals and pigments;
  • Three Delta LLP in relation to:

    • its consideration of a possible offer for J Sainsbury plc, an owner and operator of supermarkets and convenience stores; and
    • the Delta fund’s acquisition of the Senad Group and of its acquisition of the Four Seasons Health Care Group and its subsequent restructuring involving a proposed cross-border (German/English) merger under the European Directive on Cross-Border Mergers;
  • London Clubs International plc on a class 1 disposal of a casino and on its later takeover under the City Code by Harrah’s Entertainment, Inc.;
  • Gazprombank in relation to the auction of a material trading interest;
  • Gazprom neft in relation to a proposed auction of an oil field;
  • TMK Group, a listed Russian pipe producer, in relation to a proposed joint venture;
  • Ball Corporation in connection with a proposed acquisition of a Russian trading company;
  • Itera Group, a private Russian gas producer, in relation to the sale of certain assets and on a proposed joint venture;
  • Gazprombank in connection with a proposed joint venture;
  • Renaissance Capital in relation to a proposed joint venture and a number of proposed cross-border acquisitions; and
  • funds advised by Castle Harlan, Inc., a US private equity house, in its acquisition of the Polypipe Group and its subsequent restructurings and refinancings.

Credentials

Education

  • Guildford College of Law, Postgraduate Diploma of Legal Practice, 1995
  • LL.B., University of Southampton, 1992

Admissions

  • England & Wales

Robin F. Marchant

European Counsel, Mergers and Acquisitions; Private Equity
robin.marchant@skadden.com